BackgroundCheck.run
Search For

Steven M CollettiHemet, CA

Known as:
Steven Lawrence Colletti Steven L Colletti
Related to:
Adeline C Podwolsky Catherine E Anderson 60

Steven Colletti Phones & Addresses

Hemet, CA   

Murrieta, CA   

Lake Elsinore, CA   

San Diego, CA   

Riverside, CA   

Reno, NV   

39700 Ramshorn Dr, Murrieta, CA 92563   

Work

Position: Self employed

Education

Degree: High school graduate or higher
Get Report
Control this profile

Mentions for Steven M Colletti

Steven Colletti resumes & CV records

Resumes

Steven Colletti Photo 20

Steven Colletti

Steven Colletti Photo 21

Steven Colletti

Publications & IP owners

Wikipedia

Steven Colletti Photo 23

Stephen Colletti

Stephen Colletti (born February 7, 1986) is an American actor and television personality who portrayed Chase Adams on The CW Drama television series One...
Steven Colletti Photo 24

Stephen Colletti

Stephen August Colletti (born February 7, 1986) is an American actor and television personality. He was featured on the MTV reality show Laguna Beach: The ...

Us Patents

3-Imidazo[4,5-B]Pyridin-5-Ol Derivatives Useful In The Treatment Of Gpr81 Receptor Disorders

US Patent:
8507473, Aug 13, 2013
Filed:
Sep 10, 2009
Appl. No.:
13/063305
Inventors:
P. Douglas Boatman - San Diego CA, US
Benjamin R. Johnson - San Diego CA, US
Jae-Kyu Jung - San Diego CA, US
Michelle Kasem - Chula Vista CA, US
Thomas O. Schrader - San Diego CA, US
Philip J. Skinner - San Diego CA, US
Steven Colletti - Princeton Junction NJ, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 471/04
A61K 31/437
A61K 31/55
A61P 3/06
A61P 3/10
A61P 9/10
US Classification:
51421707, 514303, 546118, 540597
Abstract:
The present invention is directed to certain 3H-imidazo[4,5-b]pyridin-5-ol derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the GPR81 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of GPR81 associated disorders, for example, dyslipidemia, atherosclerosis, atheromatous disease, hypertension, coronary heart disease, stroke, insulin resistance, impaired glucose tolerance, type 2 diabetes, syndrome X, obesity, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type 1 diabetes and acne.

Tetrazole Derivatives And Methods Of Treatment Of Metabolic-Related Disorders Thereof

US Patent:
8637555, Jan 28, 2014
Filed:
Oct 29, 2004
Appl. No.:
10/535345
Inventors:
Graeme Semple - San Diego CA, US
Thomas Schrader - La Jolla CA, US
Philip J. Skinner - San Diego CA, US
Steven L. Colletti - Princeton Junction NJ, US
Tawfik Gharbaoui - Escondido CA, US
Jason E. Imbriglio - Piscataway NJ, US
Jae-Kyu Jung - San Diego CA, US
Rui Liang - East Brunswick NJ, US
Subharekha Raghavan - Teaneck NJ, US
Darby Schmidt - Clark NJ, US
James R. Tata - Westfield NJ, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/407
C07D 231/54
US Classification:
514359, 514381, 548250, 548255
Abstract:
The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor.

Tetrazole Derivatives And Methods Of Treatment Of Metabolic-Related Disorders Thereof

US Patent:
2007007, Mar 29, 2007
Filed:
Nov 17, 2006
Appl. No.:
11/601252
Inventors:
Graeme Semple - San Diego CA, US
Thomas Schrader - La Jolla CA, US
Philip Skinner - San Diego CA, US
Steven Colletti - Princeton Junction NJ, US
Tawfik Gharbaoui - Escondido CA, US
Jason Imbriglio - Piscataway NJ, US
Jae-Kyu Jung - San Diego CA, US
Rui Liang - East Brunswick NJ, US
Subharekha Raghavan - Teaneck NJ, US
Darby Schmidt - Clark NJ, US
James Tata - Westfield NJ, US
International Classification:
A61K 31/416
C07D 403/04
US Classification:
514381000, 548253000
Abstract:
The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.

Possible Relatives

David P Colletti  Debra Colletti  Daniel J Colletti  Dennis H Colletti  Diane Colletti  Frank M Colletti  Gary R Colletti  Steven D Johnson  Steven B Standiford  Steven B Standley 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.